Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Total Accrued Professional Fees, Current Legal and accounting fees Accrued Research and Development Costs and Other Accrued Research and Development Costs and Other Accrued research and development costs and other Additional Paid in Capital Additional paid-in capital Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Aggregate offering price. Aggregate Offering Price Aggregate offering price Amendment Flag Amendment Flag Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Dilutive shares not included in calculation Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Arrangements and Non-arrangement Transactions [Domain] Arrangements and Non-arrangement Transactions [Domain] Assets Total assets Assets [Abstract] ASSETS Assets, Current Total current assets Assets, Current [Abstract] Current assets: Award Type [Axis] Award Type [Axis] Basis of Accounting [Text Block] Basis of Presentation Basis of Presentation [Line Items] Basis of Presentation [Line Items] Basis of Presentation [Line Items] Basis of Presentation [Table] Basis of Presentation [Table] Basis of Presentation [Table] Cash and Cash Equivalents, at Carrying Value CASH AND CASH EQUIVALENTS, END OF PERIOD CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Cash and cash equivalents Unrestricted cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] NONCASH FINANCING ACTIVITIES: Class of Stock [Domain] Class of Stock [Domain] Class of Stock [Line Items] Class of Stock [Line Items] Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrant Issuance of warrants, price per share Class of warrant or right issued in period. Class of Warrant or Right, Issued in Period Warrants issued Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities called by warrant Commissions as percentage of gross offering proceeds. Commissions as Percentage of Gross Offering Proceeds Commission to sales agent as a percentage of gross proceeds Commitments and Contingencies Commitments and contingencies (Note 9) Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock Dividends, Shares Common stock issued for dividend Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, issued Common stock, shares, issued Common Stock, Shares, Outstanding Common stock, outstanding Common Stock, Value, Issued Common stock, $0.001 par value; 100,000,000 and 50,000,000 shares authorized at June 30, 2018 and December 31, 2017, respectively, 40,628,183 and 35,789,388 issued and outstanding at June 30, 2018 and December 31, 2017, respectively Common stock, value, issued Counterparty Name [Axis] Counterparty Name [Axis] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Current Fiscal Year End Date Current Fiscal Year End Date Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Text Block] Line of Credit Debt Instrument, Interest Rate, Stated Percentage Short term borrowing interest rate Depreciation, Depletion and Amortization Depreciation and amortization Director [Member] Director Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation Dividends Payable, Current Accrued dividends payable Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Information [Line Items] Document Information [Line Items] Document Information [Table] Document Information [Table] Document Period End Date Document Period End Date Document Type Document Type Earnings Per Share [Abstract] Earnings Per Share [Abstract] Earnings Per Share, Basic and Diluted Net loss per common share - basic and diluted Earnings Per Share [Text Block] Loss Per Share Employee-related Liabilities, Current Accrued compensation Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Unrecognized compensation cost Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Unrecognized compensation cost, recognition period Employee Stock Option [Member] Stock Options Entity Central Index Key Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity [Domain] Entity [Domain] Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Equity [Abstract] Equity [Abstract] Equity Component [Domain] Equity Component [Domain] Equity Interest Type [Axis] Equity Interest Type [Axis] Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value of Financial Instruments Fair Value Of Asset Contributed To Joint Venture Fair Value Of Asset Contributed To Joint Venture Estimated fair value of the IPR&D Contributed by SBH Federal Home Loan Banks [Abstract] Federal Home Loan Banks [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Galectin Sciences, LLC [Member] Galectin Sciences, LLC [Member] Galectin Sciences, LLC General and Administrative Expense General and administrative General and Administrative Expense [Member] General and administrative Income Statement [Abstract] Income Statement [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets In Process Research and Development [Member] In Process Research and Development Interest Expense Interest expense Interest Expense, Debt Amortization of interest expense Investment Income, Interest Interest income Investments in and Advances to Affiliates [Abstract] Investments in and Advances to Affiliates [Abstract] Investments in and Advances to Affiliates [Line Items] Investments in and Advances to Affiliates [Line Items] Investments in and Advances to Affiliates, Schedule of Investments [Text Block] Galectin Sciences LLC Investments in and Advances to Affiliates [Table] Investments in and Advances to Affiliates [Table] Issuance of Stock and Warrants for Services or Claims Issuance of common stock for services Issuance Of Warrants, Value Issuance Of Warrants, Value Warrant value Legal Entity [Axis] Legal Entity [Axis] Liabilities Total liabilities Liabilities and Equity Total liabilities, redeemable convertible preferred stock and stockholders' equity(deficit) Liabilities and Equity [Abstract] LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities, Current Total current liabilities Liabilities, Current [Abstract] Current liabilities: Line of Credit Facility [Abstract] Line of Credit Facility [Abstract] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Line of Credit Facility, Maximum Borrowing Capacity Line of credit facility Line of Credit Facility [Table] Line of Credit Facility [Table] Line of Credit, Current Line of credit current Maximum [Member] Maximum Measurement Input, Expected Term [Member] Measurement Input, Expected Term Measurement Input, Price Volatility [Member] Measurement Input, Price Volatility Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Risk Free Interest Rate Measurement Input Type [Axis] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input Type [Domain] Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Minority interest Noncontrolling Interest, Ownership Percentage by Parent Equity Method Investment, Ownership Percentage Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Income (Loss) Attributable to Parent Net loss Net loss Net Income (Loss) Available to Common Stockholders, Basic Net loss applicable to common stockholders Nonoperating Income (Expense) Total other income (expense) Nonoperating Income (Expense) [Abstract] Other income (expense): Operating Expenses Total operating expenses Operating Expenses [Abstract] Operating expenses: Operating Income (Loss) Total operating loss Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Other Agreements [Member] Other Agreements [Member] Other Agreements Other Assets, Noncurrent Other Paid-in-Kind Interest Non-cash interest expense Payables and Accruals [Abstract] Payables and Accruals [Abstract] Payments to Acquire Businesses and Interest in Affiliates Subsequent capital contribution Payments to Acquire Equity Method Investments Equity method investment in Galectin Sciences LLC Preferred Stock Dividends, Income Statement Impact Preferred stock dividends Preferred Stock, Liquidation Preference, Value Convertible preferred stock, liquidation value Preferred Stock, Shares Authorized Convertible preferred stock, shares authorized Preferred Stock, Shares Issued Convertible preferred stock, issued Preferred Stock, Shares Outstanding Convertible preferred stock, outstanding Preferred Stock, Value, Issued Convertible preferred stock, value Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Private Placement Twenty Seventeen Member. Private Placement Twenty Seventeen [Member] Private Placement 2017 Proceeds from Issuance of Common Stock Net proceeds from issuance of common stock Net proceeds from issuance of common stock and warrants Proceeds from Issuance of Private Placement Proceeds from sale of common stock Range [Axis] Range [Axis] Range [Domain] Range [Domain] Related Party [Domain] Related Party [Domain] Related Party [Axis] Related Party [Axis] Remainder Of Current Year [Member] Remainder Of Current Year [Member] Remainder Of 2018 Counterparty Name [Domain] Counterparty Name [Domain] Research and Development Expense Research and development Research and Development Expense [Member] Research and development Retained Earnings (Accumulated Deficit) Retained deficit SBH Sciences, Inc [Member] SBH Sciences, Inc [Member] SBH Sciences, Inc Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Schedule of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table Text Block] Accrued Expenses Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Dilutive Shares Which Could Exist Pursuant to Exercise of Outstanding Stock Instruments and Which were not Included in Calculation Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Stock-Based Compensation Expense Related to Common Stock Options, Restricted Common Stock and Common Stock Warrants Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of Stock Option Activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Weighted Average Assumptions Used to Determine Fair Value of Options Granted Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Common Stock Warrant Activity Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock [Member] Series A 12% convertible preferred stock Series A, B and C Preferred Stock [Member] Series and Preferred Stock [Member] Series A, B and C Preferred Stock Series B One Convertible Preferred Stock [Member] Series B One Convertible Preferred Stock [Member] Series B-1 12% convertible preferred stock Series B Three Convertible Preferred Stock [Member] Series B Three Convertible Preferred Stock [Member] Series B-3 8% convertible preferred stock Series B Two Convertible Preferred Stock [Member] Series B Two Convertible Preferred Stock [Member] Series B-2 12% convertible preferred stock Series C Preferred Stock [Member] Series C super dividend convertible preferred stock Share-based Compensation Stock-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercises in Period, Weighted Average Exercise Price Exercised Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited/cancelled Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited/cancelled Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Exercise Price Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding, June 30, 2018 Outstanding, December 31, 2017 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise Price Outstanding, June 30, 2018 Outstanding, December 31, 2017 Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend Expected dividend rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life Expected life of the options Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected Volatility Expected volatility of the underlying stock Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk free interest rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Options forfeited/cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted Number of options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant-date fair values of options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Unvested option Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Ending Balance Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Ending Balance Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Number of options vested Equity Award [Domain] Equity Award [Domain] Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Options forfeited/cancelled Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Share Price Issuance of warrants, closing price Class of Stock [Axis] Class of Stock [Axis] Equity Components [Axis] Equity Components [Axis] Statement [Line Items] Statement [Line Items] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Scenario [Axis] Scenario [Axis] Statement [Table] Statement [Table] Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Issuance of warrants, value Stock Compensation Plan [Member] Contingently Issuable Shares Stockholders' Equity Attributable to Parent Total stockholders' equity (deficit) Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity (deficit): Stockholders' Equity Note Disclosure [Text Block] Common Stock Stock Issued During Period, Shares, New Issues Shares of common stock issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised Stock Warrants Stock Warrants Text Block Common Stock Warrants Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions Ownership Percentage Supplemental Dividends on ESOP convertible preferred stock Supplemental Dividends on Esop convertible preferred stock Payment of preferred stock dividends in common stock Temporary Equity, Aggregate Amount of Redemption Requirement Convertible preferred stock, redemption value Temporary Equity, Carrying Amount, Attributable to Parent Convertible preferred stock, value Temporary Equity, Liquidation Preference Convertible preferred stock, liquidation value Temporary Equity, Shares Authorized Convertible preferred stock, shares authorized Temporary Equity, Shares Issued Convertible preferred stock, shares issued Temporary Equity, Shares Outstanding Convertible preferred stock, shares outstanding Text Block [Abstract] Text Block [Abstract] Title of Individual [Axis] Title of Individual [Axis] Relationship to Entity [Domain] Relationship to Entity [Domain] Trading Symbol Trading Symbol Two Thousand Fourteen At Market Sales Agreement [Member] Two Thousand Fourteen At Market Sales Agreement [Member] 2014 At Market Agreement Two thousand seventeen at market sales agreement. Two Thousand Seventeen at Market Sales Agreement [Member] 2017 At Market Agreement Type of Arrangement and Non-arrangement Transactions [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Undesignated Capital Stock, Par Value Undesignated Capital Stock, Par Value Undesignated stock, par value Undesignated Capital Stock, Shares Authorized Undesignated Capital Stock, Shares Authorized Undesignated stock, shares authorized Undesignated Capital Stock, Shares, Outstanding Undesignated Capital Stock, Shares, Outstanding Undesignated stock, shares designated Undesignated Capital Stock, Value Undesignated Capital Stock, Value Undesignated stock, $0.01 par value; 20,000,000 shares authorized, 20,000,000 designated at June 30, 2018 and December 31, 2017, respectively Unsecured Line Of Credit [Member] Unsecured Line Of Credit [Member] Unsecured Line Of Credit Vendor [Member] Vendor [Member] Vendor Warrant, Expiration Date Warrant, Expiration Date Warrants expiration date Warrant [Member] Warrant Warrants and rights outstanding measurement input percentage. Warrants and Rights Outstanding Measurement Input Percentage Warrants and rights outstanding, measurement input percentage Warrants and Rights Outstanding, Term Warrants and rights outstanding, term Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average common shares outstanding - basic and diluted